Federal Register / Vol. 75, No. 243 / Monday, December 20, 2010 / Notices 79343 

military readiness activities. These 

activities may incidentally take marine 

mammals present within the NWTRC 

Study Area by exposing them to sound 

from mid-frequency or high frequency 

active sonar (MFAS/HFAS) or to 

underwater detonations at levels that 

NMFS associates with the take of 

marine mammals. The Navy’s model, 

which did not factor in any potential 

benefits of mitigation measures, 

predicted that 13 individual marine 

mammals would be exposed to levels of 

sound or pressure that would result in 

injury; thus, NMFS is authorizing the 

take of 13 individuals per year by Level 

A Harassment. However, NMFS and the 

Navy have determined that injury can 

most likely be avoided through the 

implementation of the required 

mitigation measures. No mortality of 

marine mammals is anticipated or 

authorized incidental to naval exercises 

in the NWTRC. 

MIRC 

In August 2008, NMFS received an 

application from the Navy requesting 

authorization for the take of individuals 

of 26 species of marine mammals 

incidental to upcoming Department of 

Defense (including Navy, USMC, and 

USAF) training and research, 

development, testing, and evaluation 

(RDT&E) activities to be conducted 

within the MIRC study area, which 

encompasses a 501,873-square-nautical 

mile (nm2) area around the islands, 

including Guam, Tinian, Saipan, Rota, 

Farallon de Medinilla, and also includes 

ocean areas in both the Pacific Ocean 

and the Philippine Sea. These training 

activities are military readiness 

activities under the provisions of the 

NDAA. These military activities may 

incidentally take marine mammals 

present within the MIRC study area by 

exposing them to sound from midfrequency or high frequency active 

sonar (MFAS/HFAS) or underwater 

detonations. After submitting 

supplemental applications, the Navy 

requested authorization to take 

individuals of 26 species of marine 

mammals by Level B Harassment, 2 

individuals of 2 species by Level A 

Harassment annually, and 10 individual 

beaked whales by mortality over the 

course of the 5-year regulations. The 

Navy’s model, which did not factor in 

any potential benefits of mitigation 

measures, predicted that 2 individual 

marine mammals would be exposed to 

levels of sound or pressure that would 

result in injury; thus, NMFS is 

authorizing the take, by Level A 

Harassment of 2 individuals per year. 

However, NMFS and the Navy have 

determined that injury can most likely 

be avoided through the implementation 

of the Navy’s proposed mitigation 

measures. Further, although it does not 

anticipate that it will occur, the Navy 

requested, and NMFS is authorizing the 

take, by injury or mortality, of up to 10 

beaked whales over the course of the 5- 

year regulations. 

Authorizations 

NWTRC 

On November 10, 2010, NMFS’ final 

rule governing the take of marine 

mammals incidental the Navy’s 

activities in the NWTRC became 

effective. In accordance with the final 

rule, NMFS issued an LOA to the Navy 

on November 12, 2010, authorizing 

harassment of individuals or 26 species 

of marine mammals incidental to U.S. 

Navy training activities in the NWTRC. 

Issuance of this LOA is based on 

findings, described in the preamble to 

the final rule (75 FR 69296, November 

10, 2010), that the taking resulting from 

the activities described in this LOA will 

have a negligible impact on marine 

mammal stocks and will not have an 

unmitigable adverse impact on the 

availability of the affected marine 

mammal stock for subsistence uses. The 

LOA describes the permissible methods 

of taking and includes requirements 

pertaining to the mitigation, monitoring 

and reporting of such taking. 

MIRC 

On August 3, 2010, NMFS’ final rule 

governing the take of marine mammals 

incidental the Navy’s activities in the 

MIRC became effective. In accordance 

with the final rule, NMFS issued an 

LOA to the Navy on August 12, 2010, 

authorizing harassment of individuals of 

26 species of marine mammals and 

mortality of 10 individual beaked 

whales incidental to U.S. military 

training and RDT&E activities in the 

MIRC Study Area (as noted above, 

mortality of beaked whales may not 

exceed 10 individuals in the five years 

covered by the regulations). Issuance of 

this LOA is based on findings, described 

in the preamble to the final rule (75 FR 

45527, August 3, 2010), that the taking 

resulting from the activities described in 

this LOA will have a negligible impact 

on marine mammal stocks and will not 

have an unmitigable adverse impact on 

the availability of the affected marine 

mammal stock for subsistence uses. The 

LOA describes the permissible methods 

of taking and includes requirements 

pertaining to the mitigation, monitoring 

and reporting of such taking. 

Dated: December 13, 2010. 

Jolie Harrison, 

Acting Chief, Permits, Conservation, and 

Recreation, Office of Protected Resources, 

National Marine Fisheries Service. 

[FR Doc. 2010–31920 Filed 12–17–10; 8:45 am] 

BILLING CODE 3510–22–P 

COMMODITY FUTURES TRADING 

COMMISSION 

Agency Information Collection 

Activities under OMB Review 

AGENCY: Commodity Futures Trading 

Commission. 

ACTION: Notice. 

SUMMARY: In compliance with the 

Paperwork Reduction Act (44 U.S.C. 

3501 et seq.), this notice announces that 

the Information Collection Request (ICR) 

abstracted below has been forwarded to 

the Office of Management and Budget 

(OMB) for review and comment. The 

ICR describes the nature of the 

information collection and its expected 

costs and burden; it includes the actual 

data collection instruments [if any]. 

DATES: Comments must be submitted on 

or before [30 days after publication]. 

FOR FURTHER INFORMATION OR A COPY

CONTACT: John P. Dolan at (202) 418– 

5220; FAX: (202) 418–5524; e-mail: 

mailto: jdolan@cftc.gov, 

lmauldin@cftc.gov and refer to OMB 

Control No. 3038–0025. 

SUPPLEMENTARY INFORMATION: 

Title: Practice by Former Members 

and Employees of the Commission 

(OMB Control No. 3038–0025). This is 

a request for extension of a currently 

approved information collection. 

Abstract: Commission Rule 140.735–6 

governs the practice before the 

Commission of former members and 

employees of the Commission and is 

intended to ensure that the Commission 

is aware of any existing conflict of 

interest. The rule generally requires 

former members and employees who are 

employed or retained to represent any 

person before the Commission within 

two years of the termination of their 

CFTC employment to file a brief written 

statement with the Commission’s Office 

of General Counsel. The proposed rule 

was promulgated pursuant to the 

Commission’s rulemaking authority 

contained in Section 8a(5) of the 

Commodity Exchange Act, 7 U.S.C. 

12a(5) (1994), as amended. 

An agency may not conduct or 

sponsor, and a person is not required to 

respond to, a collection of information 

unless it displays a currently valid OMB 

control number. The OMB control 


jlentini on DSKJ8SOYB1PROD with NOTICES
79344 Federal Register / Vol. 75, No. 243 / Monday, December 20, 2010 / Notices 

numbers for the CFTC’s regulations 

were published on December 30, 1981. 

See 46 FR 63035 (Dec. 30, 1981). The 

Federal Register notice with a 60-day 

comment period soliciting comments on 

this collection of information was 

published on August 14, 2007 (72 FR 

45420). 

Burden statement: The respondent 

burden for this collection is estimated to 

average .10 hours per response to file 

the brief written statement. This 

estimate includes the time needed to 

review instructions; develop, acquire, 

install, and utilize technology and 

systems for the purposes of collecting, 

validating, and verifying information, 

processing and maintaining information 

and disclosing and providing 

information; adjust the existing ways to 

comply with any previously applicable 

instructions and requirements; train 

personnel to be able to respond to a 

collection of information; and transmit 

or otherwise disclose the information. 

Respondents/Affected Entities: 3. 

Estimated number of responses: 4.5. 

Estimated total annual burden on 

respondents: .10 hours. 

Frequency of collection: On occasion. 

Send comments regarding the burden 

estimated or any other aspect of the 

information collection, including 

suggestions for reducing the burden, to 

the addresses listed below. Please refer 

to OMB Control No. 3038–0025 in any 

correspondence. 

John P. Dolan, Office of General 

Counsel, U.S. Commodity Futures 

Trading Commission, 1155 21st Street, 

NW., Washington, DC 20581 and Office 

of Information and Regulatory Affairs, 

Office of Management and Budget, 

Attention: Desk Officer for CFTC, 725 

17th Street, Washington, DC 20503. 

Dated: December 15, 2010. 

David A. Stawick, 

Secretary of the Commission. 

[FR Doc. 2010–31900 Filed 12–17–10; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF DEFENSE 

Office of the Secretary 

Meeting of the Uniform Formulary 

Beneficiary Advisory Panel 

AGENCY: Assistant Secretary of Defense 

(Health Affairs), DoD. 

ACTION: Notice of meeting. 

SUMMARY: Under the provisions of the 

Federal Advisory Committee Act of 

1972 (Title 5, United States Code 

(U.S.C.), Appendix, as amended) and 

the Government in the Sunshine Act of 

1976 (5 U.S.C. 552b, as amended) the 

Department of Defense announces the 

following Federal Advisory Committee 

Meeting of the Uniform Formulary 

Beneficiary Advisory Panel (hereafter 

referred to as the Panel). 

DATES: January 6, 2011, from 9 a.m.–12 

p.m. 

ADDRESSES: Naval Heritage Center 

Theater, 701 Pennsylvania Avenue, 

NW., Washington, DC 20004. 

FOR FURTHER INFORMATION CONTACT: 

Lieutenant Colonel Stacia Spridgen, 

Designated Federal Officer, Uniform 

Formulary Beneficiary Advisory Panel 

2450 Stanley Road, Suite 208, Ft. Sam 

Houston, TX 78234–6102, Telephone: 

(210) 295–127, Fax: (210) 295–2789, Email Address: 

Baprequests@tma.osd.mil. 

SUPPLEMENTARY INFORMATION: 

Purpose of Meeting: The Panel will 

review and comment on 

recommendations made to the Director, 

TRICARE Management Activity, by the 

Pharmacy and Therapeutics Committee 

regarding the Uniform Formulary. 

Meeting Agenda: 

1. Sign-In. 

2. Welcome and Opening Remarks. 

3. Public Citizen Comments. 

4. Scheduled Therapeutic Class 

Reviews (Comments will follow each 

agenda item). 

a. Non-Insulin Anti-Diabetic Drugs. 

b. Designated Newly Approved Drugs 

in Already-Reviewed Classes. 

c. Pertinent Utilization Management 

Issues. 

d. Drugs Recommended for NonFormulary Placement Due to NonCompliance with the National Defense 

Authorization Act for Fiscal Year 2008, 

Section 703. 

5. Panel Discussions and Vote. 

Meeting Accessibility: Pursuant to 5 

U.S.C. 552b, as amended, and Title 41, 

Code of Federal Regulations (CFR), 102– 

3.140 through 102–3.165, and the 

availability of space, this meeting is 

open to the public. Seating is limited 

and will be provided only to the first 

220 people signing-in. All persons must 

sign-in legibly. 

Administrative Work Meeting: Prior to 

the public meeting, the Panel will 

conduct an Administrative Work 

Meeting from 8 a.m. to 9 a.m. to discuss 

administrative matters of the Panel. The 

Administrative Work Meeting will be 

held at the Naval Heritage Center, 701 

Pennsylvania Avenue, NW., 

Washington, DC, 20004. Pursuant to 41 

CFR 102–3.160, the Administrative 

Work Meeting will be closed to the 

public. 

Written Statements: Pursuant to 41 

CFR 102–3.105(j) and 102–3.140, the 

public or interested organizations may 

submit written statements to the 

membership of the Panel at any time or 

in response to the stated agenda of a 

planned meeting. Written statements 

should be submitted to the Panel’s 

Designated Federal Officer (DFO). The 

DFO’s contact information can be 

obtained from the General Services 

Administration’s Federal Advisory 

Committee Act Database—https:// 

www.fido.gov/facadatabase/public.asp. 

Written statements that do not pertain 

to the scheduled meeting of the Panel 

may be submitted at any time. However, 

if individual comments pertain to a 

specific topic being discussed at a 

planned meeting, then these statements 

must be submitted no later than five 

business days prior to the meeting in 

question. The DFO will review all 

submitted written statements and 

provide copies to all the committee 

members. 

Public Comments: In addition to 

written statements, the Panel will set 

aside one hour for individuals or 

interested groups to address the Panel. 

To ensure consideration of their 

comments, individuals and interested 

groups should submit written 

statements as outlined in this notice; but 

if they still want to address the Panel, 

then they will be afforded the 

opportunity to register to address the 

Panel. The Panel’s DFO will have a 

‘‘Sign-Up Roster’’ available at the Panel 

meeting, for registration on a first-come, 

first-serve basis. Those wishing to 

address the Panel will be given no more 

than five minutes to present their 

comments, and at the end of the onehour time period, no further public 

comments will be accepted. Anyone 

who signs up to address the Panel, but 

is unable to do so due to the time 

limitation, may submit comments in 

writing; however, he or she must 

understand that written comments may 

not be reviewed prior to the Panel’s 

deliberation. Accordingly, the Panel 

recommends that individuals and 

interested groups consider submitting 

written statements instead of addressing 

the Panel. 

Dated: December 14, 2010. 

Morgan F. Park, 

Alternate OSD Federal Register Liaison 

Officer, Department of Defense. 

[FR Doc. 2010–31791 Filed 12–17–10; 8:45 am] 

BILLING CODE 5001–06–P 


jlentini on DSKJ8SOYB1PROD with NOTICES